| Literature DB >> 35713877 |
Abraham S Meijnikman1,2, Casper C van Olden1, Ömrüm Aydin1,2, Hilde Herrema1, Dorota Kaminska3, Dimitra Lappa4, Ville Männistö5, Valentina Tremaroli6, Louise E Olofsson6, Maurits de Brauw2, Arnold van de Laar2, Joanne Verheij7, Victor E A Gerdes1,2, Thue W Schwartz8, Jens Nielsen4, Fredrik Bäckhed6,9,10, Päivi Pajukanta11,12, Jussi Pihlajamäki3,5, Tamar Tchkonia13, James L Kirkland13, Folkert Kuipers14, Max Nieuwdorp1, Albert K Groen1,14.
Abstract
Cellular senescence is an essentially irreversible growth arrest that occurs in response to various cellular stressors and may contribute to development of type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD). In this article, we investigated whether chronically elevated insulin levels are associated with cellular senescence in the human liver. In 107 individuals undergoing bariatric surgery, hepatic senescence markers were assessed by immunohistochemistry as well as transcriptomics. A subset of 180 participants from the ongoing Finnish Kuopio OBesity Surgery (KOBS) study was used as validation cohort. We found plasma insulin to be highly associated with various markers of cellular senescence in liver tissue. The liver transcriptome of individuals with high insulin revealed significant upregulation of several genes associated with senescence: p21, TGFβ, PI3K, HLA-G, IL8, p38, Ras, and E2F. Insulin associated with hepatic senescence independently of NAFLD and plasma glucose. By using transcriptomic data from the KOBS study, we could validate the association of insulin with p21 in the liver. Our results support a potential role for hyperinsulinemia in induction of cellular senescence in the liver. These findings suggest possible benefits of lowering insulin levels in obese individuals with insulin resistance.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35713877 PMCID: PMC9450852 DOI: 10.2337/db21-1076
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.337